Literature DB >> 11956127

Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.

Yanjuan Zhu1, Hideaki Bujo, Hiroyuki Yamazaki, Satoshi Hirayama, Tatsuro Kanaki, Kazuo Takahashi, Manabu Shibasaki, Wolfgang J Schneider, Yasushi Saito.   

Abstract

BACKGROUND: LR11, a member of the LDL receptor family, is highly expressed in vascular smooth muscle cells (SMCs) of the hyperplastic intima but not media. To further clarify the involvement of LR11 in the process of atherosclerosis, we have characterized the migration and invasion activities of LR11-overexpressing SMCs. METHODS AND
RESULTS: LR11 cDNA was transfected into the rat SMC line A7r5. Compared with mock cells (C-1), in the presence of platelet-derived growth factor-BB, the transfected cells (R-1 and R-2) showed 3.5- to 4.0-fold higher expression of LR11 protein, 1.7- to 1.8-fold increased migration, and 2.0- to 2.2-fold elevated invasion activities, respectively. The increases were essentially abolished by the addition of receptor-associated protein, anti-LR11 antibodies, or apolipoprotein E. Immunological analyses showed that urokinase-type plasminogen activator receptor (uPAR) levels were increased in LR11-overexpressing cells. Anti-urokinase-type plasminogen activator (uPA) and anti-uPAR antibodies reduced the migration and invasion activities of R-1 and R-2 cells to baseline levels. Receptor-associated protein, anti-LR11 antibodies, and apolipoprotein E decreased uPAR expression in the LR11-overexpressing cells by approximately 50%. Cellular catabolism of uPAR was significantly decreased in R-1 and R-2 cells compared with control. Cultured SMCs isolated from intima of atherosclerotic rabbit aortas showed increased expression levels of LR11 and uPAR and enhanced migration and invasion compared with SMCs from medial layers.
CONCLUSIONS: Overexpression of LR11 induces enhanced migration and invasion activities of intimal SMCs in vitro, probably through its regulation of the uPA/uPAR system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956127     DOI: 10.1161/01.cir.0000014413.91312.ef

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 2.  The Vps10p-domain receptor family.

Authors:  Guido Hermey
Journal:  Cell Mol Life Sci       Date:  2009-05-12       Impact factor: 9.261

3.  PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca2+ channels with full-length CaV1.2 C-terminus.

Authors:  Xiaoguang Guo; Toshihide Kashihara; Tsutomu Nakada; Toshifumi Aoyama; Mitsuhiko Yamada
Journal:  Pflugers Arch       Date:  2018-02-13       Impact factor: 3.657

4.  The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.

Authors:  Keigo Nishii; Chiaki Nakaseko; Meizi Jiang; Naomi Shimizu; Masahiro Takeuchi; Wolfgang J Schneider; Hideaki Bujo
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

5.  The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.

Authors:  Jørgen Gliemann; Guido Hermey; Anders Nykjaer; Claus M Petersen; Christian Jacobsen; Peter A Andreasen
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

6.  Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.

Authors:  Meizi Jiang; Hideaki Bujo; Kenji Ohwaki; Hiroyuki Unoki; Hiroyuki Yamazaki; Tatsuro Kanaki; Manabu Shibasaki; Kazuhiko Azuma; Kenichi Harigaya; Wolfgang J Schneider; Yasushi Saito
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

7.  Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.

Authors:  Elaine R Tavares; Fatima R Freitas; Jayme Diament; Raul C Maranhão
Journal:  Int J Nanomedicine       Date:  2011-10-12

8.  Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates.

Authors:  Andrew C Nyborg; Thomas B Ladd; Craig W Zwizinski; James J Lah; Todd E Golde
Journal:  Mol Neurodegener       Date:  2006-06-12       Impact factor: 14.195

9.  SorLA in Interleukin-6 Signaling and Turnover.

Authors:  Jakob Vejby Larsen; Claus Munck Petersen
Journal:  Mol Cell Biol       Date:  2017-05-16       Impact factor: 4.272

Review 10.  Sorting receptor SORLA: cellular mechanisms and implications for disease.

Authors:  Vanessa Schmidt; Aygul Subkhangulova; Thomas E Willnow
Journal:  Cell Mol Life Sci       Date:  2016-11-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.